IGC PHARMA, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2011
Total Assets: $18.2M
Liabilities Breakdown FY2011
Total Liabilities: $7.8M
Asset Breakdown
Total Assets: $18.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.6M | 8.7% |
| Accounts Receivable | $3.3M | 18.2% |
| Inventory | $133.5K | 0.7% |
| Property, Plant & Equipment | $1.2M | 6.8% |
| Goodwill | $410.5K | 2.3% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $11.5M | 63.3% |
Liabilities Breakdown
Total Liabilities: $7.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.3M | 16.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $6.5M | 83.2% |